This study is testing a new investigational influenza vaccine to find the safest and most effective dose for better prevention of influenza outbreaks. Recruiting ages 18+.
The study is being conducted at our Brisbane and Canberra clinics.
This 9-month study is evaluating whether a new, more stable formulation of an investigational dengue vaccine, containing the same active ingredients as the version approved overseas, provides comparable immune protection and safety.
This study is being conducted at our Central Coast and Western Sydney clinics.
This 14-week clinical trial aims to assess the safety and effectiveness of a potential new oral treatment in adults aged 18–65 who experience panic attacks but are not currently taking benzodiazepines or affected by other major psychiatric disorders.
This study is being conducted at our at our Western Sydney, Central Coast, Canberra, Brisbane and Melbourne sites.
Apply Now